Peroxisome proliferator-activated receptor structures: Ligand specificity, molecular switch and interactions with regulators

被引:288
作者
Zoete, Vincent
Grosdidier, Aurelien
Michielin, Olivier
机构
[1] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland
[2] Natl Ctr competence Res, Ludwig Inst Canc Res, CH-1066 Epalinges, Switzerland
[3] Univ Lausanne Hosp, Multidisciplinary Oncol Ctr, Lausanne, Switzerland
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS | 2007年 / 1771卷 / 08期
关键词
peroxisome proliferator-activated receptor; structure; activating function-2; regulators binding; ligand specificity; molecular switch;
D O I
10.1016/j.bbalip.2007.01.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Peroxisome proliferator-activated receptors (PPARs)compose a family of nuclear receptors that mediate the effects of lipidic ligands at the transcriptional level. In this review, we highlight advances in the understanding of the PPAR ligand binding domain (LBD) structure at the atomic level. The overall structure of PPARs LBD is described, and important protein ligand interactions are presented. Structure-activity relationships between isotypes structures and ligand specificity are addressed. It is shown that the numerous experimental three-dimensional structures available, together with in silico simulations, help understanding the role played by the activating function-2 (AF-2) in PPARs activation and its underlying molecular mechanism. The relation between the PPARs constitutive activity and the intrinsic stability of the active conformation is discussed. Finally, the interactions of PPARs L13D with co-activators or co-repressors, as well as with the retinoid X receptor (RXR) are described and considered in relation to PPARs activation. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:915 / 925
页数:11
相关论文
共 56 条
[1]   The mechanisms of action of PPARs [J].
Berger, J ;
Moller, DE .
ANNUAL REVIEW OF MEDICINE, 2002, 53 :409-435
[2]   Distinct properties and advantages of a novel peroxisome proliferator-activated protein γ selective modulator [J].
Berger, JP ;
Petro, AE ;
Macnaul, KL ;
Kelly, LJ ;
Zhang, BB ;
Richards, K ;
Elbrecht, A ;
Johnson, BA ;
Zhou, GC ;
Doebber, TW ;
Biswas, C ;
Parikh, M ;
Sharma, N ;
Tanen, MR ;
Thompson, GM ;
Ventre, J ;
Adams, AD ;
Mosley, R ;
Surwit, RS ;
Moller, DE .
MOLECULAR ENDOCRINOLOGY, 2003, 17 (04) :662-676
[3]   The Protein Data Bank [J].
Berman, HM ;
Battistuz, T ;
Bhat, TN ;
Bluhm, WF ;
Bourne, PE ;
Burkhardt, K ;
Iype, L ;
Jain, S ;
Fagan, P ;
Marvin, J ;
Padilla, D ;
Ravichandran, V ;
Schneider, B ;
Thanki, N ;
Weissig, H ;
Westbrook, JD ;
Zardecki, C .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2002, 58 :899-907
[4]   The Protein Data Bank [J].
Berman, HM ;
Westbrook, J ;
Feng, Z ;
Gilliland, G ;
Bhat, TN ;
Weissig, H ;
Shindyalov, IN ;
Bourne, PE .
NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :235-242
[5]   CRYSTAL-STRUCTURE OF THE LIGAND-BINDING DOMAIN OF THE HUMAN NUCLEAR RECEPTOR RXR-ALPHA [J].
BOURGUET, W ;
RUFF, M ;
CHAMBON, P ;
GRONEMEYER, H ;
MORAS, D .
NATURE, 1995, 375 (6530) :377-382
[6]   A novel partial agonist of peroxisome proliferator-activated receptor-γ (PPARγ) recruits PPARγ-coactivator-1α, prevents triglyceride accumulation, and potentiates insulin signaling in vitro [J].
Burgermeister, E ;
Schnoebelen, A ;
Flament, A ;
Benz, J ;
Stihle, M ;
Gsell, B ;
Rufer, A ;
Ruf, A ;
Kuhn, B ;
Märki, HP ;
Mizrahi, J ;
Sebokova, E ;
Niesor, E ;
Meyer, M .
MOLECULAR ENDOCRINOLOGY, 2006, 20 (04) :809-830
[7]   Design and synthesis of the first generation of dithiolane thiazolidinedione- and phenylacetic acid-based PPARγ agonists [J].
Chittiboyina, Amar G. ;
Venkatraman, Meenakshi S. ;
Mizuno, Cassia S. ;
Desai, Prashant V. ;
Patny, Akshay ;
Benson, Stephen C. ;
Ho, Christopher I. ;
Kurtz, Theodore W. ;
Pershadsingh, Harrihar A. ;
Avery, Mitchell A. .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (14) :4072-4084
[8]  
CLAM M, 2004, BIOINFORMATICS, V20, P427
[9]   Structure of the PPARα and -γ ligand binding domain in complex with AZ 242;: Ligand selectivity and agonist activation in the PPAR family [J].
Cronet, P ;
Petersen, JFW ;
Folmer, R ;
Blomberg, N ;
Sjöblom, K ;
Karlsson, U ;
Lindstedt, EL ;
Bamberg, K .
STRUCTURE, 2001, 9 (08) :699-706
[10]   Structure and specificity of nuclear receptor-coactivator interactions [J].
Darimont, BD ;
Wagner, RL ;
Apriletti, JW ;
Stallcup, MR ;
Kushner, PJ ;
Baxter, JD ;
Fletterick, RJ ;
Yamamoto, KR .
GENES & DEVELOPMENT, 1998, 12 (21) :3343-3356